JX Advanced Metals Corporation (TYO:5016)

Verve Therapeutics Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	58,316	36,779	54,775	2,609	2,040
Cash & Short-Term Investments	-	58,316	36,779	54,775	2,609	2,040
Cash Growth	-	58.56%	-32.85%	1999.46%	27.89%	-10.33%
Receivables	-	138,259	108,967	197,204	59,020	54,277
Inventory	-	273,187	254,957	612,480	120,360	104,471
Other Current Assets	-	24,473	100,484	393,103	151,295	107,872
Total Current Assets	-	494,235	501,187	1,257,562	333,284	268,660
Property, Plant & Equipment	-	371,782	328,245	291,638	104,974	92,204
Long-Term Investments	-	362,536	427,509	210,855	-	-
Goodwill	-	8,198	12,546	11,413	-	-
Other Intangible Assets	-	19,521	20,906	21,226	2,931	3,260
Long-Term Deferred Tax Assets	-	26,730	35,494	38,863	-	-
Other Long-Term Assets	-	-	-	-	345,468	341,869
Total Assets	-	1,283,002	1,325,887	1,831,557	786,657	705,993
Accounts Payable	-	92,826	70,775	220,150	30,891	29,440
Short-Term Debt	-	114,246	223,031	480,639	241,966	231,420
Current Portion of Long-Term Debt	-	6,471	-	-	-	-
Current Portion of Leases	-	3,279	3,730	4,098	-	-
Current Income Taxes Payable	-	12,434	5,968	22,378	-	-
Other Current Liabilities	-	48,669	37,222	104,483	55,285	41,033
Total Current Liabilities	-	277,925	340,726	831,748	328,142	301,893
Long-Term Debt	-	180,542	145,119	212,974	49,000	12,084
Long-Term Leases	-	16,715	16,650	21,205	-	-
Long-Term Deferred Tax Liabilities	-	23,210	22,130	20,594	-	-
Other Long-Term Liabilities	-	45,595	53,093	117,307	30,659	32,246
Total Liabilities	-	571,248	605,085	1,229,065	407,801	346,223
Common Stock	-	75,000	75,000	75,000	378,856	359,770
Additional Paid-In Capital	-	48,093	46,750	33,765	-	-
Retained Earnings	-	432,121	446,945	343,683	-	-
Treasury Stock	-	-1,000	-	-	-	-
Comprehensive Income & Other	-	61,083	58,693	39,645	-	-
Total Common Equity	-	615,297	627,388	492,093	378,856	359,770
Minority Interest	-	96,457	93,414	110,399	-	-
Shareholders' Equity	-	711,754	720,802	602,492	378,856	359,770
Total Liabilities & Equity	-	1,283,002	1,325,887	1,831,557	786,657	705,993
Total Debt	-	321,253	388,530	718,916	290,966	243,504
Net Cash (Debt)	-	-262,937	-351,751	-664,141	-288,357	-241,464
Net Cash Per Share	-	-283.20	-378.85	-715.31	-	-
Filing Date Shares Outstanding	928.34	928.46	928.46	928.46	-	-
Total Common Shares Outstanding	928.34	928.46	928.46	928.46	-	-
Working Capital	-	216,310	160,461	425,814	-	-
Book Value Per Share	-	662.70	675.73	530.01	-	-
Tangible Book Value	-	587,578	593,936	459,454	-	-
Tangible Book Value Per Share	-	632.85	639.70	494.85	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.